Cancer Research Articles

Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes Board-certified medical oncologist/hematologist Judah Friedman, MD to the statewide practice.

Pluvicto ™, the first targeted radioligand therapy approved to treat an advanced prostate cancer.

Operations for Florida Cancer Specialists & Research Institute, LLC (FCS) were halted in all but one medical office last Thursday as Hurricane Ian made its way across Florida. The state-wide practice provides oncology care in nearly 100 locations in the state.

Lucio Gordan, MD, Chief Medical Officer of Therapeutics & Analytics for Florida Cancer Specialists & Research Institute, LLC (FCS), is a featured speaker at the Illumina Genomics Forum being held this week in San Diego.

Florida Cancer Specialists & Research Institute, LLC (FCS) celebrated the groundbreaking for a new cancer center in Wesley Chapel at 30142 State Road 56, Wesley Chapel, Florida 33543.  Scheduled to open in 2024, the facility will replace the current FCS Wesley Chapel location at 26823 Tanic Drive, one of six FCS cancer centers in Pasco County.

Florida Cancer Specialists & Research Institute, LLC (FCS) has been awarded a three-year term of accreditation in radiation oncology, inclusive of each of its nine sites, as the result of a recent review by the American College of Radiology (ACR).

Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified medical oncologist and hematologist Monique Sajjad, DO, a hospitalist with the statewide practice since 2018, is now providing care to patients at the FCS Largo Diagnostic Clinic, located at 1301 2nd Ave. SW, Suite 290, Largo, FL 33770.

Research conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) is among the latest cutting-edge developments and findings in cancer care being presented at the European Society of Medical Oncology (ESMO) Congress being held this week in Paris, France.